Insiders Dump Illumina, Pfizer Directors Buy the Dip

Board member Keith Meister filed a flurry of sales in ILMN this week. His total disposals exceeded $108M across five separate transactions. Shares changed hands between $198 and $203. Meister sits on Illumina's board through his asset management firm.

At PFE, two directors moved in the opposite direction. Ronald Blaylock and Tim Buckley each filed purchases of roughly $1M worth of shares on August 5. Both paid around $25.50 per share. That coordinated buying signals fresh confidence in the beaten-down pharma giant.

JNJ CEO Joaquin Duato filed a $10.8M sale on August 7. He sold 41,957 shares at $258 each. Meanwhile, CVX saw two insiders exit. Director John Hess filed a $10.8M disposal on August 5. A second insider followed days later, pushing total Chevron sales past $26M this week.

LTH founder and CEO Bahram Akradi filed a $19.5M sale on August 4. He sold 433,000 shares near $45. Life Time Group has rallied sharply this year, making the timing notable.

Pharma buying at Pfizer stands out as the clearest bullish signal. The Illumina board exit and Chevron cluster sales paint a more cautious picture at the top.